Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Oncology & Cancer Webinars & Conferences

Asia Pacific & Middle East
Canada

Cancer diagnostics 2022

About Conference


It is our great pleasure to welcome you to the 5th Cancer Diagnostics & Treatment Conference which is an Diagnostics conference going to be held during February 14-15, 2022 at Toronto, Canada. This event is organized by Conference Series LLC Ltd, conducts 3000+ conferences every year in all the major scientific disciplines across Europe, USA & Asia which is being received by more than 25 million researchers, scholars, students all over the world.

The theme of our conference is based on “Exploring the Research Ideas in cancer Diagnostics & Treatment”. The conference invites all the cancer diagnostics, breast cancer, Cancer research and therapy, Cancer Science, Emergency medicine specialists, International speakers, Scientists, Researchers, University Professors, Students, College Faculties and Healthcare professionals to share their experience in this broad field.

Sessions and Tracks

Track 01: Cancer Development

Simply put, cancer is that the results of unregulated biological process. Cancer cells divide once they do not appear to be presupposed to, do not stop dividing once they square measure presupposed to and do not die once they have to. Among the worst cases, the cancer cells leave the earth among that they arose and travel totally different elements of the body. They changes square measure typically the results of changes to the deoxyribonucleic acid (mutations) among the cells. As a results of their square measure many alternative things that square measure capable of inflicting mutation, there square measure Associate in nursing equally sizable amount of causes of cancer, they gain new capabilities, similar to the flexibleness to unleash growth factors and method enzymes. The cells still divide, impacting shut ancient cells, typically reducing the operate of the affected organ.

Track 02: Oncology Research

Oncology is that the branch of medication that researches identifies and treats cancer. It's the procedure of treating cancer by mistreatment substances made of living organisms which might be obtainable naturally within the body or created in laboratory. They stimulate or suppress the system to assist the body fight against cancer or the other infectious diseases. This includes pathology of cancer, cancer medical specialty, acquainted cancer syndromes, differing kinds and principles of medicine, medicine nursing and care, medicine analysis and principles of multidisciplinary management.

Track 03: Cancer Science

World Oncology involves understanding the functioning and expression of oncogenes. Gene mutation or irregular functioning of signal transduction pathways results in uncontrolled cell division by blocking the pathways for programmed cell death or apoptosis. Novel therapies for cancer involve targeting these pathways for controlling tumour growth. Monoclonal antibodies, cloned genetic sequences are some of the newest approaches adopted in the mitigation of cancer.

Track 04: Cancer Treatment

Cancer treatments can cause aspect effects. Aspect affects square measure issues that occur once treatment affects healthy tissues or organs. Speak up regarding any aspect affects you have got, or changes you notice, therefore your health care team will treat or assist you to scale back these aspect effects. Differing types of treatments embody surgery, targeted medical care, secretion medical care, vegetative cell transplant, exactness medication and their several aspect effects.

Track 05: Cardio Oncology

Cardio-oncology additionally referred to as vessel medical specialty is Associate in Nursing integrative field of medication, wont to study the molecular and clinical alterations in circulatory system throughout the treatment of cancer particularly chemo and targeted medical care. Medical specialty could be a branch of medication that involves the bar, diagnosis, and treatment of cancer and Tumours. The high risk of cancer will increase with the rise in age.

Track 06: Cancer Risk Factors

It is sometimes impractical to understand precisely why one person develops cancer and another does not. However analysis has shown that bound risk factors could increase human possibilities of developing cancer. These are generally referred to as protecting risk factors or simply protecting factors. Limiting your exposure to avertable risk factors could lower your risk of developing bound cancers. It includes age, tobacco, cancer inflicting substances, obesity, alcohol, infectious agents.

Track 07: Breast Cancer, Cancer Therapies And Breast Cancer Treatment

An infection that designs in the cells of the breast. Breast Cancer can occur in Women and inconsistently in men. Signs of breast illness recall a bunch for the breast, underhanded delivery from the areola and changes in the shape or surface of the areola. Its treatment depends upon the period of harm. It may contain chemotherapy, radiation, synthetic therapy and operation.

  • Chemotherapy
  • Malignancy
  • Radiation Therapy

This part reveals to you the medicines that region unit the norm of post of beginning phase and locally progressed carcinoma. "Standard of care" proposes that the best medicines distinguished. once making treatment mastermind choices, patient's region unit propelled to ponder clinical preliminaries as partner plausibility. A test may be an examination concentrate on that tests a substitution way to deal with treatment. Specialists wish to be told whether the new treatment is protected, compelling, and apparently over the standard treatment. Clinical preliminaries will check a substitution drug and the way typically it should lean, a substitution mix of common medicines, or new portions of conventional prescription or elective medicines.

  • Partial breast irradiation
  • Routine cancer genotyping
  • Proton beam radiation

Not all young ladies with carcinoma can need chemo, but there are numerous things during which chemo could likewise be suggested: After medical procedure (adjuvant chemotherapy): Adjuvant chemo is utilized to do to kill any malignant growth cells that may are abandoned or have unfurl anyway can't be seen, even on imaging tests. On the off chance that these cells could develop, they may kind new growths in elective spots inside the body. Adjuvant chemo will bring down the shot at carcinoma returning. Prior to medical procedure (neoadjuvant chemotherapy): Neoadjuvant chemo will be acclimated endeavor to contract the neoplasm along these lines it will be taken out with less top to bottom a medical procedure. because of this, neoadjuvant chemo is typically acclimated treat malignant growths that are too immense to be in any way taken out by a medical procedure at the hour of ID (called locally progressed diseases). Likewise

  • Breast ultrasound
  • Breast Magnetic Resonance Imaging
  • Mammography

Track 08: Oncology Nursing

medical specialty nurse could be a specialised nurse World Health Organization cares for cancer patients. These nurses need advanced certifications and clinical experiences in medical specialty additional than the everyday baccalaureate nursing program provides. medical specialty medical aid will outlined as meeting the varied wants of medical specialty patients throughout the time of their sickness together with applicable screenings and different preventative practices, symptom management, care to retain the maximum amount traditional functioning as potential, and corroboratory measures upon finish of life.

Track 09: Cancer Vaccines

Cancer vaccines stimulate the immune system’s capability to protect the body against the infectious agents that may cause disease. Cancer vaccine is also known as biological response modifiers. There are two types of cancer vaccine: Preventive vaccine and treatment vaccine. The Preventive vaccine is used to stop the development of the Cancer cell and treatment vaccines are used to treat the existing cancer by natural immune system to fight against the cancer.

Oncolytic Virus is a virus that infects and breakdown Cancer cells but not normal cells. Oncolytic virus therapy may make it easier to kill tumor cells with chemotherapy and radiation therapy. It is a type of targeted therapy. Also called oncolytic virotherapy, viral therapy, and virotherapy.

  • Cancer Cell Mechanisms
  • Cancer Clinical trials
  • Cancer Epidemiology
  • Cancer Biostatistics
  • Medical Oncology
  • Interpretive Oncology

Track 10: Radiation Oncology

The use of radiation to treat cancer is outlined as Radiation medicine. X-rays, gamma rays, or electrons area unit a number of the radiations won’t to treat the Radiation medicine. Therefore Oncologists uses radiation to treat a number of the benign diseases and benign tumours. Radiation medicine is one among the first specialities of surgical and medical medicine, that area unit concerned within the treatment of cancer. The sector of radiation medicine provides the combination of irradiation into multimodal treatment approaches. Radiation medicine focuses on all aspects of analysis that impacts on the treatment of cancer victimisation radiation

Track 11: Nanotechnology In Cancer Treatment

The Nanoparticles or Nanotechnology in Cancer Treatment deals with destruction, detection, and elimination of the cancer cells with minimal harm to the healthy tissue present near. Nanoparticles are inoculated directly into the cancer cells and can destroy the proliferation of the Cancer cell present inside. Nanoparticle plays major role in drug delivery to overcome the limits of conventional treatment methods.

  • Delivering life through chemotherapy
  • Nano therapy for Cancer
  • Augmenting radiotherapy

Track 12: Cancer Stem Cells

Cancer stem cells (CSCs) measure cancer cells that possess characteristics related to traditional stem cells, specifically the flexibility to provide rise to all or any cell varieties found in an exceedingly explicit cancer sample. CSCs square measure so tumorigenic (tumour-forming), maybe in distinction to alternative non-tumorigenic cancer cells. Development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of your time amount of cancer patients, considerably for patients with biological process wellness.

Track 13: Precision Medicine And Immuno-Oncology

Precision medicine or personalized medicine is an approach to individual care for selecting treatment that are helpful to the patients based on a genetic understanding of their disease. Depending upon the type of cancer, its size and proliferation, combination of Treatment surgery, Chemotherapy, Radiation therapy and Immunotherapy may vary. But in precision medicine, information about genetic changes in the tumor can be helping to decide the Treatment.

Cancer Immunology is concerned with Immune system in progression and development of Cancer. The most well-known application is Cancer Immunotherapy where the immune system is used to treat cancer.

  • Novel concepts in Bi-specific Antibodies Engineering
  • Pre-clinical and Translational Immuno-Oncology Developments
  • Personalized Immunotherapy, Combination Immunotherapy and Viral Therapies

Track 14: Types Of Cancers

Cancer may be a common condition. It's calculable that one in 2 folks can develop some kind of cancer throughout their lifespan. Being awake to general signs and symptoms connected to the condition will facilitate in early detection. This is often vital as a result of the sooner a cancer is detected, the higher the possibilities of thriving treatment. Signs and symptoms of a number of the cancers like female internal reproductive organ cancer, cervix cancer, thyroid cancer, carcinoma, urinary organ cancer etc...

Track 15: Cancer Health Disparities

Here has been substantial progress in cancer treatment, screening, diagnosis, and prevention over the past several decades, addressing cancer health disparities—such as higher cancer death rates, less frequent use of proven screening tests, and higher rates of advanced cancer diagnoses—in certain populations is an area in which progress has not kept pace.

These disparities are frequently seen in people from low-socioeconomic groups, certain racial/ethnic populations, and those who live in geographically isolated areas.

Documented cancer health disparities include: A higher incidence of a particularly aggressive form of breast cancer (the triple-negative subtype) among African American women than women of other racial/ethnic groups

substantially higher rates of prostate cancer incidence and death among African American men than men of other racial/ethnic groups

higher rates of kidney cancer among American Indian and Alaska Natives than other racial/ethnic groups. Higher rates of liver cancer among Asian and Pacific Islanders than other racial/ethnic groups

higher rates of cervical cancer incidence and death among Hispanic and African American women than women of other racial/ethnic groups. Many of the same population groups that experience cancer health disparities are also significantly underrepresented in cancer clinical trials.

There has been some recent evidence of progress against cancer health disparities, including reductions in lung and prostate cancer deaths among African American men over the past decade. But researchers and public health officials agree that progress has come too slowly, and the cost of disparities—in terms of premature deaths, lost productivity, and the impact on communities—remains substantial and must be addressed. Cancer disparities and equity research is needed to understand why some groups of people may be more or less likely to develop cancer, experience cancer-related health problems, or die from cancer than other groups of people.

Track 16: Organ Specific Cancer

Cancer may be a condition wherever cells in a very specific a part of the body grow and reproduce infinitely. The willcerous cells can enter and destroy encompassing healthy tissues together with organs. There are differing types of cancer supported location of cancer within the body. A number of the organ cancers such as carcinoma and epithelium, carcinoma, body part cancer, cancer of oesophagus , Cervical cancer ,Endometrial cancer, Head and Neck cancers and cancers of unknown primary.

Track 17: Pulmonary Oncology

Our cancer doctors establish tumours, blockages or internal haemorrhage and use advanced carcinoma treatments to cut back or eliminate symptoms. Treatment-related facet effects: Some carcinoma treatments, like therapy, might cause scarring within the lungs. Whereas we tend to attempt to scale back these facet effects, aggressive carcinoma treatment might cause ineluctable complications. We tend to use sure interventional pulmonology procedures to treat your symptoms and to differentiate between a facet result of treatment and therefore the progression of cancer.

Track 18: Cancer Preventive Vaccines: Oncolytic Therapy & Others

Cancer vaccines stimulate the immune system’s capability to protect the body against the infectious agents that may cause disease. Cancer vaccine is also known as biological response modifiers. There are two types of cancer vaccine: Preventive vaccine and treatment vaccine. The Preventive vaccine is used to stop the development of the Cancer cell and treatment vaccines are used to treat the existing cancer by natural immune system to fight against the cancer.

Oncolytic Virus is a virus that infects and breakdown Cancer cells but not normal cells. Oncolytic virus therapy may make it easier to kill tumor cells with chemotherapy and radiation therapy. It is a type of targeted therapy. Also called oncolytic virotherapy, viral therapy, and virotherapy.

  • Cancer Cell Mechanisms
  • Cancer Clinical trials
  • Cancer Epidemiology
  • Cancer Biostatistics
  • Medical Oncology
  • Interpretive Oncology

Track 19: Cancer Epidemiology, Screening, Diagnosis & Prognosis

The Epidemiology of Cancer is the investigation of the components influencing Cancer, an approach to finish up potential inclinations and causes. The investigation of Cancer Epidemiology rehearses Epidemiological Methods to find the reason for Cancer and to perceive and create upgraded medicines. This degree of concentrate must adapt to challenges of lead time predisposition and length time inclination. Lead time inclination is the hypothesis that essential conclusion may falsely expand the endurance measurements of a Cancer, without really improving the characteristic history of the illness. Length predisposition is the idea that delicate developing, progressively torpid Tumors are bound to be perceived by Screening Tests, yet upgrades in diagnosing more instances of lethargic Cancer may not convert into better patient results after the execution of Screening Programs.

Most Cancers are initially known either in light of the presence of signs or indications or through Screening. Neither of these prompts a Definitive Diagnosis, which involves the assessment of a tissue test by a pathologist. Individuals with suspected Cancer are seen with medicinal tests. These for the most part incorporate Blood Tests, CT Scans, X-beams and Endoscopy.

Screenings can discover introductory Cancer, when it's generally reparable. Disease Screening means to recognize Cancer before manifestations show up. This may incorporate blood tests, pee tests, different tests, or Medical Imaging.

  • Microfluidic device for cancer screening
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Circulating tumor cells (CTCs) towards cancer Diagnosis
  • Cohort studies and Cancer Survival analysis

Track 20: Phases And Types Of Clinical Trails

Different types of clinical trials performed on cancer patients supported their sort of cancer. Clinical trials are going to be differentiated supported sort of cancer. Part l trials are the ultimate step during a long method that begins with analysis during a laboratory. Before any new treatment is employed with folks in clinical trials, researchers work for several years to know its effects on cancer cells within the laboratory and in animals. They additionally try and puzzle out the aspect effects it should cause. Clinical trials sometimes include treatment trails, preventive trails, screening trails, palliative care trails.

Track 21: Cancer Biology

The science that deals with cancer cells area unit called Cancer Biology. The most aim of cancer biology is to grasp the abrupt modification in cells and the way it's developed and varied from traditional cells to cancer cells. These manners of analysis in cancer biology have arranged a path to hindrance, identification and treatment. Tumours are unit thought-about by genomic and epigenetic uncertainty that modifies the needs of assorted altered particles and systems during a solo cell still as varied the communications with the native scenario. Cancer systems biology attitudes, therefore, area unit grounded on the custom of machine and precise systems to translate the complication in growth creation still as cancer no uniformity.

Track 22: Circulating Tumor Cell (CTC)

Circulating Tumor Cell are the cells that are shed into the lymphatic or vasculature stream from a tumor and remain loose in circulation, cluster together as they travel or lodge themselves in new tissues. The detection of Circulating tumor cell has important Diagnostic and Therapeutic implication then their number can be very small and cells are not certainly identified.

  • Methods of CTC detection
  • CTC number as a surrogate response and prognostic biomarker
  • CTC chip technology and EGFR mutation analysis
  • Application of CTC technologies to clinical testing

Track 23: Gynecologic Oncology

Gynaecologic medical specialty could be a specialised field of medication that focuses on cancers of the feminine system, as well as gonad cancer, female internal reproductive organ cancer, canal cancer, cervical cancer, and vulvar cancer. As specialists, they need intensive coaching within the diagnosing and treatment of those cancers.

Track 24: Neonatal And Pediatric Oncology

Neonatal medical specialty may be a sub specialty of medical specialty that deals with the hindrance, diagnosis, and treatment of cancer in babies. New born cancer is rare and contains a heterogeneous cluster of neoplasms with substantial microscopic anatomy diversity. The causes of infant cancer are unclear; however genetic factors in all probability have a key role.

Track 25: Cancer Biomarkers

Cancer biomarkers talk to a molecule or substance secreted by the body in response to presence of tumour cells within the body. Biomarkers are wont to establish early stage cancer, or to diagnose the wellness condition of patient. It may also be wont to outline the prophetic treatment or monitor the treatment method given to the patients.

Track 26: Genetic Mutations Of Cancer

Cancers are caused by a change in, or damage to one or more genes. Mutations can stop genes from working properly. Gene mutations happen when we are born with a mutated gene that is either inherited from a parent or that develops in an embryo and also when we are exposed to something around us that damages our genes, like cigarette smoke. It takes more than one gene mutation for a cell to become cancerous .But there are also cancers where we don’t know which gene mutations cause them.

Track 27: Veterinary Oncology

Many cancers in veterinary oncology are detected only when they are very advanced. Part of this is because our patients cannot tell us when something just isn't right, but also because they will carry on appearing relatively normal to the client but just ‘slowing down’. Many cancers are occult and it may be some time before an obvious abnormality becomes apparent. Offering good diagnostic evaluations early will improve prompt detection of cancer and the opportunity to treat patients early; this in itself will improve survival times for many patients.

Track 28: Cancer Drugs

The implementation of new drug treatments has improved the prognosis for advanced cancer of the cervix, uterus, and ovary. Platinum analogs are the most effective drugs in the treatment of ovarian cancer. Fertility drugs (FD) are spreading worldwide fast and therefore many studies have reviewed the possible association between the use of these drugs and cancer. Since the drugs used for ovulation induction during in-vitro fertilization (IVF) like hCG, hMG, rFSH increase the levels of gonadal hormones, concerns have grown regarding the risk of developing cancer in breast, ovary, endometrium, and other target organs. If the treatment plan involves chemotherapy you may experience physical, emotional, and/or psychological side effects related to this treatment. The side effects of ovarian cancer treatment depend on the type of treatment and may be different for each woman.

  • New Drugs in Gynaecologic Cancer
  • Fertility Drugs and Gynaecologic Cancer
  • Side Effects of Drugs
  • Pharmaceutical management

Market Analysis

The global cancer therapy market was valued at USD 136,25(Cancer diagnostics 2022)

4.35 million in 2018, and is estimated to be valued at USD 220,701.26 million in 2024, witnessing a CAGR of 8.37%. Certain factors that are driving the market growth include increasing Patient Assistance Programs (PAPs), increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and powerful R&D initiatives from key players. Cancer therapeutics involves the utilization and administration of chemotherapy and oncology drugs to treat cancer. Worldwide cancer affects quite 10 million people annually and thus the incidence of cancer is predicted to extend by 2.4% annually to realize 14 million once a year by 2021. Cancer is that the second commonest death within the industrialized world.

The target therapy segment is predicted to means absolutely the best CAGR of 9.68% during the forecast period. The target therapy includes hormone therapies, phenomenon modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells. Quite 45 million Americans don't have insurance and millions more are underinsured; eight out of 10 uninsured people are from working families. Among those with insurance, one out of ten people, sixty five years previous or younger, and one in 3 persons over sixty five years do not have medicine coverage.

The carcinoma segment is believed to account for the foremost important market size over the forecast period. This is often majorly attributed to the upper and continuously increasing prevalence of carcinoma across the world. As per estimates provided by the carcinoma Organization in 2018, it's estimated that over 2,66,120 new cases of invasive carcinoma are expected to be diagnosed in women within the us , in conjunction with 63,960 new cases of non-invasive (in situ) carcinoma . North America currently dominates the marketplace for cancer therapy and is predicted to continue its stronghold for a couple of years. This region is predicted to extend its market share within the long run, because of the increased adoption of cancer therapy. US holds majority of the market within the North American region, due to the rising prevalence of cancer within the country. Consistent with the National Cancer Institute (NCI), in 2016, 1.6 million people suffered from cancer, and around 0.5 million people died from cancer. This figure indicates that the prevalence of cancer is rapidly increasing within the US.

Hence, Patients help Programs (PAPs) have emerged during an effort to help patients United Nations agency are lacking insurance or prescription coverage get the medication they need . These programs area unit provided by pharmaceutical firms to supply free or affordable prescription drugs to patients World Health Organization area unit suffering from serious sicknesses. Several big pharmaceutical companies, like Pfizer and Eli lily, have also started these programs to assist uninsured patients who are affected by chronic diseases. Thus, an oversized range of uninsurable patients, suffering from cancer, can also bare cancer therapies that are likely to strengthen the expansion of the market.

To Collaborate Scientific Professionals around the World

Conference Date February 14-15, 2022

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by